The risk of serious blood clot formation was found to be higher in men with prostate cancer when compared with men of the same age without prostate cancer, according to a study published in the online journal Cancer. line Open BMJ.
Prostate cancer is a cancer most often diagnosed in middle-aged and older men. In general, people with cancer have a higher risk of developing one type of blood clot – venous thromboembolism (VTE) – Blood clots in the veins are dangerous but treatable.
Men with prostate cancer have a 50% higher risk of developing serious and potentially fatal blood clots within 5 years. ‘
Prostate cancer and blood clots
VTE is known to be the leading cause of death among people with cancer, especially advanced diseases – two to three times more common in men with prostate cancer.
Although prostate cancer risk is smaller than for other cancers, study encourages clinicians warning of this risk so that it can be diagnosed and treated promptly, if a blood clot occurs.
It is seen that 3.2% of men in the prostate cancer group experienced VTE within about five years of their cancer diagnosis, compared with 2.1% of men in the comparison group.
“The magnitude of the increase in VTE risk in men with prostate cancer seen in our study was lower than with other cancers seen in previous studies and may be due to the proportion of men men with high myelopathy and low cancer risk Physicians treating prostate cancer should be aware of the markedly increased risk of VTE in these men, especially during the first six months of life. after cancer diagnosis, to help ensure a timely diagnosis of VTE,” the authors concluded.